Medactive Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.60 M
as on 19-12-2024
- Paid Up Capital ₹ 0.60 M
as on 19-12-2024
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -35.03%
(FY 2022)
- Profit 99.97%
(FY 2022)
- Ebitda 101.12%
(FY 2022)
- Net Worth -0.04%
(FY 2022)
- Total Assets -19.64%
(FY 2022)
About Medactive Pharmaceuticals
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.60 M and a paid-up capital of Rs 0.60 M, as per Ministry of Corporate Affairs (MCA) records.
Arpna Kumari, Ripu Mishra, Manish Kumar, and One other member serve as directors at the Company.
- CIN/LLPIN
U51900BR2019PTC042018
- Company No.
042018
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 May 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Begusarai, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Medactive Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arpna Kumari  | Director | 13-May-2019 | Current |
| Ripu Mishra | Director | 12-Aug-2020 | Current |
| Manish Kumar | Director | 13-May-2019 | Current |
| Nil Kamal | Director | 13-May-2019 | Current |
Financial Performance of Medactive Pharmaceuticals.
Medactive Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 35.03% decrease. The company also saw a substantial improvement in profitability, with a 99.97% increase in profit. The company's net worth dipped by a decrease of 0.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medactive Pharmaceuticals?
Unlock access to Medactive Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Amritjeevan Hospital Private LimitedActive 6 years 10 monthsArpna Kumari, Manish Kumar and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medactive Pharmaceuticals?
Unlock and access historical data on people associated with Medactive Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medactive Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medactive Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
